Ann: Becoming a substantial holder, page-16

First 16 Last

Share
Profile

Follow
AlCp

26,688 Posts.

1732

22/09/17

17:33

Post #: 27403683
Share

Originally posted by TerribleTadpole ↑

I've said this several times before... the Australian studies weren't trials at all. They were studies designed to:
a) Gather symptoms and cough data for a bunch of patients, and the condition each patient was diagnosed with.
b) Train a classifier algorithm with the data and diagnoses.
c) Test the trained classifier (using leave-one-out) to measure the effectiveness of the training.

You can't use the training data to prove the training was effective. That's why we're initiating the new double-blind Australian trials.

I have a colleague at work who loves asking questions like, "what do we need to allow for that we haven't thought of?"

It seems like a stupid question. How can we think of what we haven't thought of?

But we can't possibly be the first company to ever try to collect sounds in a hospital or medical centre. Who else has attempted something like this? What snags did they hit? What did they do? Was there anything they luckily allowed for because it happened?

A quick search of ClinicalTrials.gov using cough sounds as the keywords turns up our study plus 12 others. Some can be ruled out as completely different: ultrasound images, neurological responses to sounds. But I can see 6 studies that can't be ruled out instantly. There might be more studies in archives or other medical resources. Perhaps some of those studies included sound recordings taken in hospitals. Perhaps some of those other organisations might be prepared to discuss issues they experienced or were able to predict with their trials.

If we could learn from other peoples' experiences it would be a whole lot better and cheaper than learning from our own mistakes!

PS: I hate working with the guy who asks about what we haven't thought of. He frustrates the heck out of me!

Expand

And that is why management were confident to do the clinical trials at the US with these Australian results......and from memory, RAP said these were complex FDA clinical trials (first ever????)

Last edited by AlCp: 22/09/17

RAP Price at posting: 7.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

RCE

Recce's R327 found effective against E.coli during clinical trial

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Microcap Wrap: 5 explorers with news out today

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom